House Passes Bill Targeting Orphan Drug Exclusivity
The U.S. House of Representatives on Tuesday passed a bill that would require drugmakers to prove they don't expect to recoup research and development costs through sales of a new drug...To view the full article, register now.
Already a subscriber? Click here to view full article